Pfizer and BioNTech have formally asked for FDA approval of a third dose of their ... those seen after the two-dose primary schedule," said Pfizer chief executive Albert Bourla.
SAN FRANCISCO — At the end of a roundtable lunch with a group of reporters, Pfizer CEO Albert Bourla became impassioned. He admitted that after the company made a “big miscalculation” around ...
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the JPMorgan ...
Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...
Albert Bourla, CEO of Pfizer since 2019, led the company through a global pandemic and rapidly developed and deployed a vaccine that was eventually taken by millions. That move alone nearly ...
Few CEOs know the double-edged nature of dealing with US President Donald Trump as viscerally as Pfizer’s Albert Bourla. In his first term, Trump championed the $18 billion Operation Warp Speed ...
Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting ...
(Reuters) -U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results